The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists.

Chantal VisserJoseph S BiedermannMelchior C NiermanFelix J M van der MeerAnouk J W GulpenYvonne C F MoorsSuzanne C CannegieterWillem M LijferingMarieke J H A Kruipnull null

Published in: Thrombosis and haemostasis (2022)

BNT162b2 was associated with an immediate negative effect on anticoagulation control in patients treated with VKAs, so it is advisable to monitor the INR shortly after vaccination, even in stable patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
venous thromboembolism
coronavirus disease